METASTRON Side Effects

7020722-6 | Abasia, Bladder Tamponade, Condition Aggravated, Malignant Neoplasm Progression, Metastatic Carcinoma Of The Bladder, Metastatic Pain, Platelet Count Decreased, Sepsis
on Sep 15, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, bladder tamponade, condition aggravated, malignant neoplasm progression, metastatic carcinoma of the bladder, metastatic pain, platelet count decreased, sepsis (What is sepsis?). Metastron dosage: Single Dose, I.v..

6979474-8 | Gastric Cancer, Large Intestine Carcinoma, Malignant Neoplasm Progression, Shock Haemorrhagic
Patient was taking Metastron (View Usage). Patient had the following side effects: gastric cancer, large intestine carcinoma, malignant neoplasm progression, shock haemorrhagic on Aug 30, 2010 from Additional patient health information: Female patient , 71 years of age, weighting 93.70 lb, was diagnosed with metastatic pain and. Metastron dosage: 85 Mbq, Single Dose, I.v.. Patient was hospitalized.

6940196-0 | No Adverse Event
Adverse event was reported on Jan 26, 2009 by a Female patient taking Metastron (View Usage) (Dosage: Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 69 years of age, After Metastron was administered, patient had the following side effects: no adverse event.

6917314-3 | Anaemia, Disease Progression, Prostate Cancer
on Jul 30, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, disease progression, prostate cancer (What is prostate cancer?). Metastron dosage: Single Dose, I.v..


6917289-7 | Anaemia, Breast Cancer Female, Malignant Neoplasm Progression
on Jul 30, 2010 Female patient from JAPAN , 64 years of age, weighting 81.79 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: anaemia, breast cancer female, malignant neoplasm progression. Metastron dosage: 74 Mbq, Single Dose, I.v.. Patient was hospitalized.

6900593-6 | Blood Urea Increased, Disseminated Intravascular Coagulation, Dyspnoea, Gastrointestinal Haemorrhage, Haematuria, Haemoglobin Decreased, Movement Disorder, Oesophageal Candidiasis, Platelet Count Decreased
Patient was taking Metastron (View Usage). After Metastron was administered, patient had the following side effects: blood urea increased, disseminated intravascular coagulation, dyspnoea, gastrointestinal haemorrhage, haematuria, haemoglobin decreased, movement disorder (What is movement disorder?), oesophageal candidiasis, platelet count decreased on Jul 12, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with metastatic pain and. Metastron dosage: 3.8 Ml, Single Dose, I.v.. Patient was hospitalized.

6897902-3 | Anaemia, Disseminated Intravascular Coagulation, Sepsis
Adverse event was reported on Jul 14, 2010 by a Male patient taking Metastron (View Usage) (Dosage: 82 Mbq, Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 77 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: anaemia, disseminated intravascular coagulation, sepsis (What is sepsis?). Patient was hospitalized.

6862363-7 | Blood Pressure Decreased, Depressed Level Of Consciousness, Fatigue, Miosis, Tachycardia, Unresponsive To Stimuli
on Jul 05, 2010 Male patient from JAPAN , 82 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: blood pressure decreased, depressed level of consciousness, fatigue, miosis, tachycardia, unresponsive to stimuli. Metastron dosage: Single Dose, I.v.. Patient was hospitalized.

6821707-2 | Anaemia, Breast Cancer Metastatic, Hot Flush, Malignant Neoplasm Progression, Metastases To Kidney, Metastases To Liver, Metastases To Lung, Multi-organ Failure
on Jun 22, 2010 Female patient from JAPAN , 65 years of age, weighting 132.3 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: anaemia, breast cancer metastatic, hot flush, malignant neoplasm progression, metastases to kidney, metastases to liver, metastases to lung, multi-organ failure. Metastron dosage: 118 Mbq, Single Dose, I.v.. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE (HYSRON H) (View Medroxyprogesterone Acetate (hysron-h) Review and Medroxyprogesterone Acetate (hysron-h) Label ). Patient was hospitalized.

6811851-8 | Anaemia
Patient was taking Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia on Jun 14, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, weighting 120.2 lb, was diagnosed with metastatic pain and. Metastron dosage: Single Dose, I.v.. Patient was hospitalized.

6782808-0 | Lung Cancer Metastatic, Pyrexia, Respiratory Failure
Adverse event was reported on Sep 29, 2009 by a Female patient taking Metastron (View Usage) (Dosage: 67 Mbq, Single Dose, I.v.) was diagnosed with metastases to bone and. Location: JAPAN , 73 years of age, weighting 72.75 lb, Patient had the following side effects: lung cancer metastatic, pyrexia, respiratory failure.

6754372-3 | Haemoglobin Decreased
on May 19, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: haemoglobin decreased. Metastron dosage: 106 Mbq, Single Dose, I.v..

6741985-8 | Breast Cancer Female, Dementia, Malignant Neoplasm Progression
on Apr 16, 2010 Female patient from JAPAN , 67 years of age, weighting 116.8 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer female, dementia (What is dementia?), malignant neoplasm progression. Metastron dosage: Single Dose, I.v.. During the same period patient was treated with FENTANYL (DUROTEP) (View Fentanyl (durotep) Review and Fentanyl (durotep) Label ), MORPHINE HYDROCHLORIDE (OPSO) (View Morphine Hydrochloride (opso) Review and Morphine Hydrochloride (opso) Label ).

6741983-4 |
Patient was taking Metastron (View Usage). on Nov 10, 2009 from JAPAN Additional patient health information: Male patient , 65 years of age, weighting 130.7 lb, was diagnosed with metastatic pain and. Metastron dosage: Single Dose, I.v..

6713944-2 | Anaemia, Bone Marrow Failure, Disease Progression, Metastases To Bone, Neck Pain, Platelet Count Decreased, Prostatic Specific Antigen Increased, Pyrexia, White Blood Cell Count Decreased
Adverse event was reported on Apr 22, 2010 by a Male patient taking Metastron (View Usage) (Dosage: 132 Mbq, Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 79 years of age, weighting 154.3 lb, After Metastron was administered, patient had the following side effects: anaemia, bone marrow failure, disease progression, metastases to bone, neck pain, platelet count decreased, prostatic specific antigen increased, pyrexia, white blood cell count decreased. During the same period patient was treated with ESTRAMUSTINE (View Estramustine Review and Estramustine Label ). Patient was hospitalized.

6713924-7 | Platelet Count Decreased, Pulmonary Haemorrhage
on Apr 21, 2010 Male patient from JAPAN , 75 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased, pulmonary haemorrhage. Metastron dosage: 116 Mgq, Single Dose, I.v.. Patient was hospitalized.

6713875-8 | Constipation, Diarrhoea, Gastritis, Oesophageal Candidiasis, Pain, Platelet Count Decreased
on Apr 22, 2010 Male patient from JAPAN , 77 years of age, weighting 154.3 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: constipation (What is constipation?), diarrhoea, gastritis, oesophageal candidiasis, pain (What is pain?), platelet count decreased. Metastron dosage: 140 Mbq, Single Dose, I.v.. Patient was hospitalized.

6713424-4 | Decreased Appetite, Diarrhoea, Headache, Otitis Media Chronic, Platelet Count Decreased, Urinary Tract Infection
Patient was taking Metastron (View Usage). After Metastron was administered, patient had the following side effects: decreased appetite, diarrhoea, headache (What is headache?), otitis media chronic, platelet count decreased, urinary tract infection (What is urinary tract infection?) on Apr 22, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, weighting 154.3 lb, was diagnosed with metastatic pain and. Metastron dosage: 140 Mbq, Single Dose, I.v.. Patient was hospitalized.

6691532-4 | Bone Marrow Failure, Disseminated Intravascular Coagulation
Adverse event was reported on Apr 08, 2010 by a Male patient taking Metastron (View Usage) (Dosage: Nr, Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 73 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, disseminated intravascular coagulation.

6681676-5 | Back Pain, Bone Marrow Failure, Pleural Effusion
on Apr 02, 2010 Male patient from JAPAN , 86 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: back pain (What is back pain?), bone marrow failure, pleural effusion. Metastron dosage: 141 Mgq, Single Dose, I.v.. Patient was hospitalized.

6668516-5 | Anaemia, Disease Progression, Nausea
on Mar 25, 2010 Female patient from JAPAN , 49 years of age, weighting 146.6 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: anaemia, disease progression, nausea (What is nausea?). Metastron dosage: 2 Mbq/kg, Single Dose, I.v.. Patient was hospitalized.

6667815-0 | Disseminated Intravascular Coagulation, Neutrophil Count Decreased
Patient was taking Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, neutrophil count decreased on Mar 23, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with metastatic pain and. Metastron dosage: 114 Mbq, Single Dose, I.v.. Patient was hospitalized.

6648591-4 | Blood Calcium Increased, Condition Aggravated, Decreased Appetite, Nausea
Adverse event was reported on Mar 11, 2010 by a Female patient taking Metastron (View Usage) (Dosage: 78 Mbq, Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 59 years of age, Patient had the following side effects: blood calcium increased, condition aggravated, decreased appetite, nausea (What is nausea?).

6636526-X | Epistaxis, Fall, Head Injury, Platelet Count Decreased, Subdural Haemorrhage, Subdural Hygroma
on Feb 22, 2010 Female patient from JAPAN , 75 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: epistaxis, fall (What is fall?), head injury, platelet count decreased, subdural haemorrhage, subdural hygroma. Metastron dosage: Nr, Single Dose I.v..

6617014-3 | Anaemia, Back Pain, Gastrointestinal Perforation, Malignant Neoplasm Progression, Perineal Pain, Prostate Cancer, Pubic Pain, Pyrexia
on Feb 19, 2010 Male patient from JAPAN , 64 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, back pain (What is back pain?), gastrointestinal perforation, malignant neoplasm progression, perineal pain, prostate cancer (What is prostate cancer?), pubic pain, pyrexia. Metastron dosage: 3.8 Ml, Single Dose, I.v.. Patient was hospitalized.

6611022-4 | Bone Marrow Failure, Decreased Appetite, Pyrexia
Patient was taking Metastron (View Usage). Patient had the following side effects: bone marrow failure, decreased appetite, pyrexia on Feb 09, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, weighting 112.4 lb, was diagnosed with metastatic pain and. Metastron dosage: , Single Dose, I.v.. During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ). Patient was hospitalized.

6589528-6 | Fall, Head Injury, Platelet Count Decreased, Subdural Haemorrhage
Adverse event was reported on Feb 02, 2010 by a Female patient taking Metastron (View Usage) (Dosage: Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 75 years of age, After Metastron was administered, patient had the following side effects: fall (What is fall?), head injury, platelet count decreased, subdural haemorrhage.

6589362-7 | Blood Calcium Increased
on Jan 29, 2010 Female patient from JAPAN , 59 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: blood calcium increased. Metastron dosage: 76 Mbq, Single Dose, I.v.. Patient was hospitalized.

6566469-1 | Bone Marrow Failure, Hepatic Neoplasm Malignant, Malignant Neoplasm Progression
on Dec 28, 2009 Male patient from JAPAN , 59 years of age, weighting 112.4 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: bone marrow failure, hepatic neoplasm malignant, malignant neoplasm progression. Metastron dosage: 102 Mbq, Single.

6539043-0 |
Patient was taking Metastron (View Usage). on Dec 24, 2009 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with metastatic pain and. Metastron dosage: Single Dose, I.v..

6536527-6 | Condition Aggravated, Decreased Appetite, Diarrhoea, Gastritis, Headache, Oesophageal Candidiasis, Pain, Platelet Count Decreased, Urinary Tract Infection
Adverse event was reported on Aug 21, 2009 by a Male patient taking Metastron (View Usage) (Dosage: 140 Mbq, Single Dose, I.v.; Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 77 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: condition aggravated, decreased appetite, diarrhoea, gastritis, headache (What is headache?), oesophageal candidiasis, pain (What is pain?), platelet count decreased, urinary tract infection (What is urinary tract infection?). Patient was hospitalized.

6442547-2 | Decreased Appetite, Malignant Neoplasm Progression, Nasopharyngeal Cancer, Nausea
on Oct 29, 2009 Male patient from JAPAN , 50 years of age, weighting 146.6 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: decreased appetite, malignant neoplasm progression, nasopharyngeal cancer, nausea (What is nausea?). Metastron dosage: 3.5 Ml, Single Dose, Iv.

6419484-2 | Anaemia, Concomitant Disease Progression
on Oct 19, 2009 Male patient from JAPAN , 54 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: anaemia, concomitant disease progression. Metastron dosage: Single Dose, I.v..

6354722-6 | Malaise, Metastases To Central Nervous System, Nausea
Patient was taking Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, metastases to central nervous system, nausea (What is nausea?) on Aug 25, 2009 from JAPAN Additional patient health information: Female patient , 45 years of age, weighting 96.78 lb, was diagnosed with metastatic pain and. Metastron dosage: 81.8 Mbq, Single Dose, I.v.. Patient was hospitalized.

6337159-5 | Anaemia, Bone Marrow Failure, Condition Aggravated, Decreased Appetite, Depressed Level Of Consciousness, Diarrhoea, Epistaxis, Gingival Bleeding, Malaise
Adverse event was reported on Aug 19, 2009 by a Female patient taking Metastron (View Usage) (Dosage: Single Dise, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 63 years of age, weighting 77.16 lb, Patient had the following side effects: anaemia, bone marrow failure, condition aggravated, decreased appetite, depressed level of consciousness, diarrhoea, epistaxis, gingival bleeding, malaise.

6312385-X | Cerebral Infarction, Eating Disorder, Malignant Neoplasm Progression, Metastatic Pain, Platelet Count Decreased
on Aug 04, 2009 Male patient from JAPAN , 70 years of age, weighting 99.21 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: cerebral infarction, eating disorder (What is eating disorder?), malignant neoplasm progression, metastatic pain, platelet count decreased. Metastron dosage: 2.9 Ml, Single Dose, I.v.; , Single Dose, I.v.. Patient was hospitalized.

6312384-8 | Anaemia, Disease Progression, Prostate Cancer, Pyrexia
on Aug 05, 2009 Male patient from JAPAN , 67 years of age, weighting 120.4 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, disease progression, prostate cancer (What is prostate cancer?), pyrexia. Metastron dosage: , Single Dose, I.v.. Patient was hospitalized.

6299254-9 | Anaemia, Back Pain, C-reactive Protein Increased, Disease Progression, Gastrointestinal Perforation, Nausea, Perineal Pain, Peritonitis, Pubic Pain
Patient was taking Metastron (View Usage). Patient had the following side effects: anaemia, back pain (What is back pain?), c-reactive protein increased, disease progression, gastrointestinal perforation, nausea (What is nausea?), perineal pain, peritonitis, pubic pain on Jul 27, 2009 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with metastatic pain and. Metastron dosage: Single Dose, I.v.. Patient was hospitalized.

6295234-8 | Activities Of Daily Living Impaired, Anaemia, Condition Aggravated, Delirium, Prostate Cancer
Adverse event was reported on Jul 17, 2009 by a Male patient taking Metastron (View Usage) (Dosage: Single Dose,) was diagnosed with metastatic pain and. Location: JAPAN , 77 years of age, weighting 98.99 lb, After Metastron was administered, patient had the following side effects: activities of daily living impaired, anaemia, condition aggravated, delirium, prostate cancer (What is prostate cancer?). During the same period patient was treated with ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ). Patient was hospitalized.

6289204-3 | Blood Calcium Increased, Malaise
on Jul 14, 2009 Male patient from JAPAN , 65 years of age, was diagnosed with bone pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: blood calcium increased, malaise. Metastron dosage: Single Dose, I.v.. Patient was hospitalized.

6275049-7 | Anaemia, Breast Cancer Female, Condition Aggravated, Eating Disorder, Hot Flush, Hypoaesthesia, Malignant Neoplasm Progression, Nausea, Pain
on Jul 08, 2009 Female patient from JAPAN , 45 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: anaemia, breast cancer female, condition aggravated, eating disorder (What is eating disorder?), hot flush, hypoaesthesia, malignant neoplasm progression, nausea (What is nausea?), pain (What is pain?). Metastron dosage: Single Dose, I.v.. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ZOLEDRONIC ACID HYDRATE (ZOMETA) (View Zoledronic Acid Hydrate (zometa) Review and Zoledronic Acid Hydrate (zometa) Label ). Patient was hospitalized.

6269346-9 | Anaemia, Gingival Bleeding
Patient was taking Metastron (View Usage). After Metastron was administered, patient had the following side effects: anaemia, gingival bleeding on Jul 01, 2009 from JAPAN Additional patient health information: Female patient , 51 years of age, was diagnosed with metastatic pain and. Metastron dosage: Single Dose, I.v..

6265022-7 | Anaemia, Condition Aggravated, Disease Progression, Nausea, Pain
Adverse event was reported on Jun 25, 2009 by a Male patient taking Metastron (View Usage) (Dosage: 108 Mbq, Single Dose, I.v.) was diagnosed with metastatic pain and. Location: JAPAN , 62 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, condition aggravated, disease progression, nausea (What is nausea?), pain (What is pain?). During the same period patient was treated with FLUOROURACIL W/FOLINIC ACID/IRINOTECAN (FOLFIRI) (View Fluorouracil W/folinic Acid/irinotecan (folfiri) Review and Fluorouracil W/folinic Acid/irinotecan (folfiri) Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6257633-X | Headache, Vomiting
on Jun 23, 2009 Female patient from JAPAN , 60 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient had the following side effects: headache (What is headache?), vomiting. Metastron dosage: Nr, Single Dose, I.v.. Patient was hospitalized.

6251228-X | Anaemia
on Jun 18, 2009 Male patient from JAPAN , 61 years of age, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: anaemia. Metastron dosage: 108 Mbq, Single Dose, I.v.. During the same period patient was treated with FLUOROURACIL W/FOLINIC ACID/IRINOTECAN (FOLFIRI) (View Fluorouracil W/folinic Acid/irinotecan (folfiri) Review and Fluorouracil W/folinic Acid/irinotecan (folfiri) Label ).

6238875-6 | Bone Marrow Failure, Disseminated Intravascular Coagulation, Gastrointestinal Haemorrhage, Multi-organ Failure
Patient was taking Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, disseminated intravascular coagulation, gastrointestinal haemorrhage, multi-organ failure on Jun 08, 2009 from JAPAN Additional patient health information: Male patient , 66 years of age, weighting 154.3 lb, was diagnosed with bone pain and. Metastron dosage: Single Dose, I.v.. Patient was hospitalized.

6238866-5 | Anaemia, Condition Aggravated, Lung Neoplasm Malignant, Metastases To Liver, Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Jun 11, 2009 by a Female patient taking Metastron (View Usage) (Dosage: Single Dose, I.v.) was diagnosed with metastatic pain and. Location: , 60 years of age, weighting 90.39 lb, Patient had the following side effects: anaemia, condition aggravated, lung neoplasm malignant, metastases to liver, platelet count decreased, white blood cell count decreased. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), VINCRISTINE SULFATE (VNR) (View Vincristine Sulfate (vnr) Review and Vincristine Sulfate (vnr) Label ). Patient was hospitalized.

6237802-5 | Condition Aggravated, Malignant Neoplasm Progression, Pain, Prostate Cancer Metastatic
on Jun 03, 2009 Male patient from JAPAN , 72 years of age, weighting 95.90 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). After Metastron was administered, patient had the following side effects: condition aggravated, malignant neoplasm progression, pain (What is pain?), prostate cancer metastatic. Metastron dosage: 88 Mbq, Singledose, I.v.. Patient was hospitalized.

6220202-1 | Diarrhoea, Haemoglobin Decreased, Platelet Count Decreased, Red Blood Cell Count Decreased, Sepsis, White Blood Cell Count Decreased
on May 28, 2009 Male patient from JAPAN , 59 years of age, weighting 121.3 lb, was diagnosed with metastatic pain and was treated with Metastron (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, haemoglobin decreased, platelet count decreased, red blood cell count decreased, sepsis (What is sepsis?), white blood cell count decreased. Metastron dosage: 110 Mbq, Single Dose, I.v.. During the same period patient was treated with AMRUBICIN HYDROCHLORIDE (View Amrubicin Hydrochloride Review and Amrubicin Hydrochloride Label ).

6207524-5 | Anorectal Disorder, Anorexia, Bladder Disorder, Blood Pressure Decreased, Bone Pain, Condition Aggravated, Constipation, Decubitus Ulcer, Depressed Level Of Consciousness
Patient was taking Metastron (View Usage). Patient had the following side effects: anorectal disorder, anorexia, bladder disorder, blood pressure decreased, bone pain, condition aggravated, constipation (What is constipation?), decubitus ulcer, depressed level of consciousness on May 13, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, weighting 143.3 lb, was diagnosed with metastatic pain and. Metastron dosage: I.v.. Patient was hospitalized.